Should I Buy AIZ? AIZ 2026 Analysis

Should You Buy Assurant Inc (AIZ) Today? Analysis, Price Targets, and 2026 Outlook.

Conclusion

Buy

Latest Price

237.290

1 Day change

0.10%

52 Week Range

243.750

Analysis Updated At

2026/01/28

Buy for a long-term beginner now. Assurant’s latest quarter (2025/Q3) showed strong growth (revenue +8.57% YoY, EPS +103.14% YoY), Wall Street price targets have been raised repeatedly into year-end, and options positioning (put/call OI 0.49) skews bullish. Technically, the stock is neutral-to-slightly soft but is trading just above the key pivot/support zone (~235.6), which is an acceptable entry for an impatient long-term investor. **Intellectia Proprietary Trading Signals** - [AI Stock Picker](module://ai_stock_pick): No signal on given stock today. - [SwingMax](module://swingmax): No signal on given stock today.

Technical Analysis

Pre-market ~236.81, sitting slightly above the Pivot 235.639 (near-term support). RSI(6) 54.47 is neutral (no overbought/oversold). MACD histogram -0.681 is below zero but negatively contracting, suggesting bearish momentum is easing rather than accelerating. Moving averages are converging (trend is not strong). Near-term levels: Support S1 232.277 (then S2 230.201); Resistance R1 239.001 (then R2 241.077). Overall: consolidation/sideways with mild downside pressure fading; acceptable buy zone near pivot with resistance overhead around 239–241.

Options Data

Bullish

Open Interest Put-Call Ratio

Bullish

Option Volume Put-Call Ratio

Open interest favors calls (put/call OI 0.49), which is generally bullish positioning. However, today’s options volume is effectively zero, so sentiment is based more on positioning than active new betting. Implied vol (30D ~21.56) is modest with low IV rank (4.3) and percentile (27.2), implying options markets are not pricing in major near-term shock.

Technical Summary

Sell

Buy

Positive Catalysts

1) Strong 2025/Q3 profitability jump (net income +98.51% YoY, EPS +103.14% YoY) supports confidence in earnings power.
2) Analyst sentiment has improved with multiple price target raises (UBS, BMO, Morgan Stanley, Keefe Bruyette, Piper Sandler).
3) Low/contained implied volatility suggests no major near-term fear priced in.
4) Next earnings: 2026-02-10 (After Hours) with EPS estimate 5.55 could be a catalyst if results/guide beat.

Neutral/Negative Catalysts

1) Technicals are not in a strong uptrend (MACD still negative; overhead resistance near 239–241).
2) Short-term pattern-probability data flags mild downside over the next month (-1.23% expected bias), implying possible chop after entry.
3) Morgan Stanley highlighted a potentially softening property & casualty cycle heading into 2026 (could temper future multiple expansion).
4) No recent news catalysts; the stock may drift until the next earnings/updates.

Financial Performance

Latest reported quarter: 2025/Q3. Revenue rose to $3.232B (+8.57% YoY). Net income rose to $265.6M (+98.51% YoY). EPS increased to 5.18 (+103.14% YoY). This is a strong acceleration in profitability versus revenue growth, indicating improving margins/underwriting and/or operating leverage trends in the quarter.

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

Recent trend: predominantly positive with a clear pattern of price target increases from November through December 2025. UBS reiterated Buy (PT 257). BMO reiterated Outperform (PT 246). Keefe Bruyette reiterated Outperform (PT 254). Piper Sandler reiterated Overweight (PT 264). Morgan Stanley stayed Equal Weight but still raised PT (248). Wall Street pros: consistent PT raises, confidence in business momentum, benefits from AI/automation and strong claims environment commentary. Wall Street cons: at least one major firm remains neutral (Equal Weight) and notes a potentially softening industry cycle into 2026.

7 Analyst Rating

Wall Street analysts forecast AIZ stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for AIZ is 255.67 USD with a low forecast of 246 USD and a high forecast of 265 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

6 Buy

1 Hold

0 Sell

Strong Buy

Current: 237.050

Low

246

Averages

255.67

High

265

Current: 237.050

Low

246

Averages

255.67

High

265

Piper Sandler

Overweight

maintain

$252 -> $264

AI Analysis

2025-12-19

Reason

Piper Sandler

Price Target

$252 -> $264

AI Analysis

2025-12-19

maintain

Overweight

Reason

Piper Sandler raised the firm's price target on Assurant to $264 from $252 and keeps an Overweight rating on the shares. The firm is generally above consensus for most of insurtech. The claims environment has been strong, while AI and automation in insurance is borne out and seen directly in this group.

Keefe Bruyette

Outperform

maintain

$248 -> $254

2025-11-20

Reason

Keefe Bruyette

Price Target

$248 -> $254

2025-11-20

maintain

Outperform

Reason

Keefe Bruyette raised the firm's price target on Assurant to $254 from $248 and keeps an Outperform rating on the shares. The firm still expects positive momentum across the business units, the analyst tells investors in a research note.

Unlock Full Analyst Thesis， Get the complete breakdown of rating reason for AIZ

Unlock Now

AIZ Should I Buy

AIZ Should I Buy

Should You Buy Assurant Inc (AIZ) Today? Analysis, Price Targets, and 2026 Outlook.

Technical Analysis

Options Data

Technical Summary

Positive Catalysts

Neutral/Negative Catalysts

Financial Performance

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

People Also Watch